BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34399860)

  • 21. Interventions for acute otitis externa.
    Kaushik V; Malik T; Saeed SR
    Cochrane Database Syst Rev; 2010 Jan; (1):CD004740. PubMed ID: 20091565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-analysis of the efficacy of quinolone containing otics in comparison to antibiotic-steroid combination drugs in the local treatment of otitis externa.
    Mösges R; Nematian-Samani M; Hellmich M; Shah-Hosseini K
    Curr Med Res Opin; 2011 Oct; 27(10):2053-60. PubMed ID: 21919557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiology of otitis externa in the secondary care in United Kingdom and antimicrobial sensitivity.
    Ninkovic G; Dullo V; Saunders NC
    Auris Nasus Larynx; 2008 Dec; 35(4):480-4. PubMed ID: 18314283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current therapeutical management, new antibiotics and treatment of Pseudomonas aeruginosa in bacterial ENT-infections].
    Elies W
    Laryngorhinootologie; 2002 Jan; 81(1):40-5. PubMed ID: 11845401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciprofloxacin in the treatment of malignant external otitis.
    Gehanno P
    Chemotherapy; 1994; 40 Suppl 1():35-40. PubMed ID: 7805430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bacterial otitis externa with invasion of organ limits--systemic and local combination treatment with ciprofloxacin].
    Ganz H
    Z Arztl Fortbild (Jena); 1993 Apr; 87(5):413-5. PubMed ID: 8322469
    [No Abstract]   [Full Text] [Related]  

  • 27. Ordering and interpreting ear swabs in otitis externa.
    Llor C; McNulty CA; Butler CC
    BMJ; 2014 Sep; 349():g5259. PubMed ID: 25179670
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative efficacy of aminoglycoside versus fluoroquinolone topical antibiotic drops.
    Manolidis S; Friedman R; Hannley M; Roland PS; Matz G; Rybak L; Stewart MG; Weber P; Owens F
    Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S83-8. PubMed ID: 15054366
    [No Abstract]   [Full Text] [Related]  

  • 29. Malignant otitis externa: an Asian perspective on treatment outcomes and prognostic factors.
    Loh S; Loh WS
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):991-6. PubMed ID: 23558287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of bacterial pathogens and antibiotic susceptibility patterns in chronic suppurative otitis media.
    Mofatteh MR; Shahabian Moghaddam F; Yousefi M; Namaei MH
    J Laryngol Otol; 2018 Jan; 132(1):41-45. PubMed ID: 29151379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment patterns for otitis externa.
    Halpern MT; Palmer CS; Seidlin M
    J Am Board Fam Pract; 1999; 12(1):1-7. PubMed ID: 10050637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The species composition and sensitivity of pathogenic microflora responsible for the development of otitis externa diffusa to the components of Polidexa].
    Krasnozhen VN; Pokrovskaya EM; Bayazitova LT
    Vestn Otorinolaringol; 2018; 83(1):65-67. PubMed ID: 29488502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa.
    Martín Barrasa JL; Lupiola Gómez P; González Lama Z; Tejedor Junco MT
    J Vet Med B Infect Dis Vet Public Health; 2000 Apr; 47(3):191-6. PubMed ID: 10829573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and antibiotic susceptibility of bacterial isolates from dogs with otitis externa in Australia.
    Bugden DL
    Aust Vet J; 2013; 91(1-2):43-6. PubMed ID: 23356371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the effectiveness of Syzygium aromaticum, Lavandula angustifolia and Geranium robertianum essential oils in the treatment of acute external otitis: a comparative trial with ciprofloxacin.
    Panahi Y; Akhavan A; Sahebkar A; Hosseini SM; Taghizadeh M; Akbari H; Sharif MR; Imani S
    J Microbiol Immunol Infect; 2014 Jun; 47(3):211-6. PubMed ID: 23274083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A worrying development in the microbiology of otitis externa.
    Walshe P; Rowley H; Timon C
    Clin Otolaryngol Allied Sci; 2001 Jun; 26(3):218-20. PubMed ID: 11437845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development of antibiotic resistant organisms with the use of ototopical medications.
    Weber PC; Roland PS; Hannley M; Friedman R; Manolidis S; Matz G; Owens F; Rybak L; Stewart MG
    Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S89-94. PubMed ID: 15054367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity and spectrum of bacterial isolates in infectious otitis externa.
    Arshad M; Khan NU; Ali N; Afridi NM
    J Coll Physicians Surg Pak; 2004 Mar; 14(3):146-9. PubMed ID: 15228846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates from dogs with otitis externa.
    Mekić S; Matanović K; Šeol B
    Vet Rec; 2011 Jul; 169(5):125. PubMed ID: 21742683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.